Ramsay Générale de Santé S.A.
GDS.PA · PAR
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | €5,242 | €5,007 | €4,702 | €4,301 |
| % Growth | 4.7% | 6.5% | 9.3% | – |
| Cost of Goods Sold | €1,158 | €1,064 | €979 | €891 |
| Gross Profit | €4,084 | €3,943 | €3,723 | €3,410 |
| % Margin | 77.9% | 78.7% | 79.2% | 79.3% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €0 | €699 | €85 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €3,897 | €3,758 | €96 | €3,117 |
| Operating Expenses | €3,897 | €3,758 | €3,503 | €3,117 |
| Operating Income | €187 | €184 | €218 | €281 |
| % Margin | 3.6% | 3.7% | 4.6% | 6.5% |
| Other Income/Exp. Net | -€221 | -€225 | -€131 | -€96 |
| Pre-Tax Income | -€33 | -€41 | €88 | €185 |
| Tax Expense | €2 | -€4 | €24 | €57 |
| Net Income | -€54 | -€54 | €49 | €118 |
| % Margin | -1% | -1.1% | 1.1% | 2.8% |
| EPS | -0.49 | -0.49 | 0.45 | 1.07 |
| % Growth | 0% | -208.9% | -57.9% | – |
| EPS Diluted | -0.49 | -0.49 | 0.45 | 1.07 |
| Weighted Avg Shares Out | 110 | 110 | 110 | 110 |
| Weighted Avg Shares Out Dil | 110 | 110 | 110 | 110 |
| Supplemental Information | – | – | – | – |
| Interest Income | €5 | €27 | €9 | €1 |
| Interest Expense | €215 | €205 | €165 | €129 |
| Depreciation & Amortization | €434 | €427 | €403 | €377 |
| EBITDA | €600 | €585 | €647 | €677 |
| % Margin | 11.4% | 11.7% | 13.8% | 15.7% |